Main Menu

Cancer Genetics, Inc.

(NASDAQ CM: CGIX)

Rigrodsky Law, P.A. is investigating Cancer Genetics, Inc. (“Cancer Genetics”) regarding possible breaches of fiduciary duties and other violations of law related to Cancer Genetics’ agreement to merge with StemoniX, Inc. ("StemoniX").  Under the terms of the agreement, Cancer Genetics will issue a number of shares of Cancer Genetics common stock to StemoniX shareholders.

Join This Action

Alternatively, you may upload your transactions using the upload button below or email them to info@rl-legal.com.

Draw your signature below using your mouse* [Clear]

Signed pursuant to California Civil Code Section 1633.1, et seq. - and the Uniform Electronic Transactions Act as adopted by the various states and territories of the United States.

Date of signing: 01/23/2021


* Indicates a required field.

Back to Page